Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.

ABSTRACT:

SUBMITTER: Gritti G 

PROVIDER: S-EPMC8142063 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature